AU1809499A - Self-emulsifying fenofibrate formulations - Google Patents

Self-emulsifying fenofibrate formulations

Info

Publication number
AU1809499A
AU1809499A AU18094/99A AU1809499A AU1809499A AU 1809499 A AU1809499 A AU 1809499A AU 18094/99 A AU18094/99 A AU 18094/99A AU 1809499 A AU1809499 A AU 1809499A AU 1809499 A AU1809499 A AU 1809499A
Authority
AU
Australia
Prior art keywords
emulsifying
self
fenofibrate formulations
fenofibrate
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18094/99A
Inventor
Awadhesh K. Mishra
Iskandar Moussa
Indu Parikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RTP Pharma Inc
Original Assignee
RTP Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US98827097A priority Critical
Priority to US08988270 priority
Priority to US4994298A priority
Priority to US09049942 priority
Application filed by RTP Pharma Inc filed Critical RTP Pharma Inc
Priority to PCT/US1998/026075 priority patent/WO1999029300A1/en
Publication of AU1809499A publication Critical patent/AU1809499A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
AU18094/99A 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations Abandoned AU1809499A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US98827097A true 1997-12-10 1997-12-10
US08988270 1997-12-10
US4994298A true 1998-03-30 1998-03-30
US09049942 1998-03-30
PCT/US1998/026075 WO1999029300A1 (en) 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations

Publications (1)

Publication Number Publication Date
AU1809499A true AU1809499A (en) 1999-06-28

Family

ID=26727723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18094/99A Abandoned AU1809499A (en) 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations

Country Status (2)

Country Link
AU (1) AU1809499A (en)
WO (1) WO1999029300A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT318132T (en) * 1998-03-30 2006-03-15 Jagotec Ag Compositions comprising microparticles of water insoluble substances, as well as processes for their preparation
US6337092B1 (en) 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances
CA2331640A1 (en) * 1998-05-07 1999-11-11 Elan Corporation Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
JP2002540174A (en) * 1999-03-31 2002-11-26 アボット・ラボラトリーズ New formulations containing lipid regulating agent
WO2000057859A1 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
US6372251B2 (en) * 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
AU2006201100B2 (en) * 1999-09-21 2009-09-24 Jagotec Ag Surface modified particulate compositions of biologically active substances
KR100801588B1 (en) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 Surface Modified Particulate Compositions of Biological Active Substances
AT296091T (en) * 1999-09-21 2005-06-15 Skyepharma Canada Inc Surface-modified particulate compositions of biologically active materials
AU7638200A (en) * 1999-10-20 2001-04-30 Vesifact Ag Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions
FR2803203B1 (en) * 1999-12-31 2002-05-10 Fournier Ind & Sante New galenic formulations of fenofibrate
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB0119480D0 (en) * 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
EP1539117A4 (en) * 2002-06-28 2005-12-14 Shire Lab Inc Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
DE60229450D1 (en) 2002-12-13 2008-11-27 Jagotec Ag Topical nanoparticle-spironolactone formulation
US20050074469A1 (en) * 2003-10-03 2005-04-07 Charles Signorino Stable lipophilic emulsions for acrylic coating and method of making
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
JP4994039B2 (en) * 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド Useful micellar system for delivery of fat-soluble or hydrophobic compound
US7790190B2 (en) * 2004-03-20 2010-09-07 Yasoo Health, Inc. Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid
US20090149533A1 (en) * 2004-08-06 2009-06-11 Transform Pharmaceuticals, Inc. Novel fenofibrate formulations and related methods of treatment
US8026281B2 (en) 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
CA2617805A1 (en) * 2005-08-04 2007-02-15 Transform Pharmaceuticals, Inc. Novel formulations comprising fenofibrate and a statin, and related methods of treatment
WO2008144355A2 (en) * 2007-05-17 2008-11-27 Morton Grove Pharmaceuticals, Inc. Stable, self-microemulsifying fenofibrate compositions
US20100173882A1 (en) 2009-01-08 2010-07-08 Lipocine, Inc. Steroidal Compositions
KR101966874B1 (en) 2009-03-09 2019-04-08 프로노바 바이오파마 너지 에이에스 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
CN102802624A (en) * 2009-06-19 2012-11-28 太阳医药高级研发有限公司 Nanodispersion Of A Drug And Process For Its Preparation
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
EP2878311A1 (en) * 2013-11-27 2015-06-03 Freund Pharmatec Ltd. Solubility Enhancement for Hydrophobic Drugs
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (en) * 1984-06-08 1985-12-19 Rentschler Arzneimittel Lipid Nano pellets as traegersystem for drug for oral application
FR2617047B1 (en) * 1987-06-23 1991-05-10 Sanofi Sa gelatin resistant composition for tanning, capsules based on this composition and their pharmaceutical use, particularly fenofibrate
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie New dosage form of fenofibrate
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
FR2730231B1 (en) * 1995-02-02 1997-04-04 Fournier Sca Lab Association of fenofibrate and vitamin E, therapeutic use
FR2737121B1 (en) * 1995-07-27 1997-10-03 Cl Pharma New galenic formulations of fenofibrate and their applications

Also Published As

Publication number Publication date
WO1999029300A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU4040197A (en) Microturbomachinery
AU2845197A (en) Cycloalkano-pyridines
AU7672498A (en) Interactive game system
AU4648296A (en) Self propelled saw
AU6190498A (en) Resilient foot insert
EP1049486A4 (en) Glp-1 formulations
AU5083498A (en) Stable glassy state powder formulations
AU1523597A (en) Triclosan-containing medical devices
AU707949C (en) Anthelmintic formulations
AU6097298A (en) Tetrahydrolipstatin containing compositions
AU6948098A (en) Locking-cylinder supported surgical boot
AU6242998A (en) Hand held video game
AU9623898A (en) Vaccines
IL127915D0 (en) Thermadol multiple unit formulations
AU4414997A (en) Toy construction set
AUPO203996A0 (en) Therapeutic uses
AU2839997A (en) Medical devices
AUPN864296A0 (en) Descender
AU1408199A (en) Patient support surfaces
AU5872696A (en) Endoscope
AU1123997A (en) Directly compressible high load acetaminophen formulations
AU5154196A (en) Puzzle
AU7412798A (en) Opsistor image processor
AUPO425496A0 (en) Medical humidifier

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase